Hyperfractionated Radiotherapy of Bladder Cancer: A ten-year follow-up of a randomized clinical trial

References

• Suit H D. Statement of the problems pertaining to the effect of dose fractionation and total treatment time on response of tissue to X-irradiation. Time and dose relationships in radiation biology as applied to radiotherapy. Brookhaven National Laboratory, Apton, New York 1970; 7
   Google Scholar
• Fowler J F. La Ronde—radiation sciences and medical radiology. Radiother Oncol 1983; 1: 1–22
   PubMedGoogle Scholar
• Howard-Flanders P, Alper T. The sensitivity of microorganisms to irradiation under controlled gas conditions. Radiat Res 1957; 7: 518–40
   PubMed Web of Science ®Google Scholar
• Van den Brenk H AS. Increased radiosensitivity of skin in humans irradiated in 4 ATA oxygen pressure. Frontiers of radiation therapy and oncology, J M Vaeth. Karger, Basel 1968; vol 1: 141
   Google Scholar
• Clifton K H, Brigg R C, Stone H B. Quantitative radiosensitivity studies of solid carcinomas in vivo: Methodology and effect of anoxia. J Natl Cancer Inst 1966; 36: 965–74
   Google Scholar
• Hewitt H D, Chan D OS, Blake E R. Survival curves for clonogenic cells of a murine creatinizing squamous carcinoma irradiated in vivo or under hypoxic conditions. Int J Radiat Biol Relat Stud Phys Chem Med 1967; 12: 535–49
   PubMed Web of Science ®Google Scholar
• Van Putten L M, Kallman R F. Oxygenation status of a transplantable tumour during fractionation radiation therapy. J Natl Cancer Inst 1968; 40: 441–51
   PubMedGoogle Scholar
• Reinhold H S. Quantitative evaluation of the radiosensitivity of cells of a transplantable rhabdomyosarcoma in the rat. Eur J Cancer 1966; 2: 33–42
   PubMedGoogle Scholar
• Chapman J ID, Gillespie C J, Reuvers A P, Dugle D LV. Ra-dioprotectors, radiosensitizers, and the shape of the mammalian cell survival curve. Proc 6th L.H. Gray Conference, London. T Alper. The Inst. of Physics, and John Wiley and Sons Ltd., London and New York 1975; 135–40
   Google Scholar
• Littbrand B. Survival characteristics of mammalian cell lines after single or multiple exposures to roentgen radiation under oxic or anoxic condition. Acta Radiol 1970; 9: 257–81
   Web of Science ®Google Scholar
• McNally N J. The effect of repeated small doses of radiation on recovery from sublethal damage by Chinese hamster cells irradiated in oxic or hypoxic conditions in the plateau phase of growth. Proc 6th L.H. Gray Conference, London. T Alper. The Inst. of Physics, and John Wiley and Sons Ltd., London and New York 1975; 119–25
   Google Scholar
• Nias A HW, Gilbert C W. Response of HeLa and Chinese hamster cells to low-doses of photons and neutrons. Proc 6th L.H. Gray Conference, London. T Alper. The Inst. of Physics and John Wiley and Sons Ltd., London and New York 1975; 93–99
   Google Scholar
• Revesz L, Littbrand B, Midander J, Scott O CA. Oxygen effect in the shoulder region of cell survival curves. Proc 6th L.H. Gray Conference, London. T Alper. The Inst. of Physics and John Wiley and Sons Ltd., London and New York 1975; 141–8
   Google Scholar
• Koch C J. Measurements of very low oxygen tensions in liquids: does extra-polation number for mammalian survival curves decreases after x-irradiation and anoxic condition?. Proc 6th L.H. Gray Conference, London. T Alper. The Inst. of Physics and John Wiley and Sons Ltd., London and New York 1975; 167–173
   Google Scholar
• Palcic B, Skarsgaard L D. Reduced oxygen enhancement ratio at low doses of ionizing radiation. Radiat Res 1984; 100: 328–39
   PubMed Web of Science ®Google Scholar
• Thomas H D, Jr, Peters L G, Withers H R, Fletcher G H. Accelerated fractionation vs hyper-fractionation: rationals for several treatments per day. Int J Radiat Oncol Biol Phys 1983; 9: 127–38
   PubMed Web of Science ®Google Scholar
• Peto R, Pike M C, Armitage P. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. Br J Cancer 1977; 35: 1–39
   PubMed Web of Science ®Google Scholar
• Edsmyr F, Andersson K, Esposti P L, Littbrand B, Nilsson B. Irradiation therapy with multiple small fractions per day in urinary bladder cancer. Radiother Oncol 1985; 4: 197–203
   PubMed Web of Science ®Google Scholar
• Rojas A. Arcon accelerated radiotherapy with carbogen and nicotinamide. Br J Radiol 1992; 24(Suppl)174–8
   Google Scholar
• Henk J M. Late results of trial of hyperbaric oxygen and radiotherapy in head and neck cancer: A rational for hypoxic cell sensitizers?. Int J Radiat Oncol Biol Phys 1986; 12: 1339–41
   PubMed Web of Science ®Google Scholar
• Watson E L, Halman K E, Dische S. Hyperbaric oxygen and radiotherapy: an MRC trial in carcinoma of the cervix. Br J Radiol 1978; 51: 879–87
   PubMed Web of Science ®Google Scholar
• Overgaard J, Hansen H S, Andersen A J. Misonidazole combined with split-course radiotherapy in the treatment of invasive carcinoma of the larynx and pharynx. Final report from DAHANCA 2 study. Int J Radiat Oncol Biol Phys 1989; 16: 1065–8
   PubMed Web of Science ®Google Scholar
• Withers H R. Cell cycle redistribution as a factor in multi-fractionation irradiation. Radiology 1975; 114: 199–202
   PubMed Web of Science ®Google Scholar
• Fowler J F. Fractionation radiotherapy after Strandqvist. Acta Radiol 1984; 23: 209–16
   Web of Science ®Google Scholar
• Bäckström A, Jakobsson P Å, Littbrand B, Wersäll I. Fractionation scheme with low individual doses in irradiation of carcinoma of the mouth. Acta Radiol 1973; 12: 401–6
   Web of Science ®Google Scholar
• Jakobsson P Å, Littbrand B. Fractionation scheme with low individual tumour dose and high total dose. Acta Radiol 1973; 12: 337–46
   Web of Science ®Google Scholar
• Littbrand B, Edsmyr F, Révész L. A low dose fractionation scheme for the radiotherapy of the carcinoma of the bladder. Experimental and preliminary results. Bull Cancer 1975; 62: 241
   PubMed Web of Science ®Google Scholar
• Ellis F. Dose, time and fractionation. A clinical hypothesis. Clin Radiol 1969; 20: 1–7
   PubMedGoogle Scholar
• Williams M V, Denekamp J, Fowler J F. A review of α/β ratios for experimental tumours: Implications for clinical studies of altered fractionation. Int J Radiat Oncol Biol Phys 1985; 11: 87–96
   PubMed Web of Science ®Google Scholar
• Sanchiz F, Milla A, Torner J. Single fraction per day versus two fractions per day versus radiochemotherapy in the treatment of head and neck cancer. Int J Radiat Oncol Biol Phys 1990; 19: 1347–50
   PubMed Web of Science ®Google Scholar
• Horiot J C, Le Fur R, N'Gauen T. Hyperfractionation versus conventional fractionation in oropharyngeal carcinoma: final analysis of a randomized trial of the EORTC cooperative group of radiotherapy. Radiother Oncol 1992; 25: 231–41
   PubMed Web of Science ®Google Scholar
• Thames H D, Bentzen S M, Turesson I, Overgaard M, van den Bogaert W. Time-dose factors in radiotherapy: A review of the human data. Radiother Oncol 1990; 19: 219–35
   PubMed Web of Science ®Google Scholar
• Wheeler K T, Nelson G B. Saturation of DNA repair process in dividing and nondividing mammalian cells. Radiat Res 1987; 109: 109–17
   PubMed Web of Science ®Google Scholar
• Linsteadt D, Edwards M, Prados M, Larson D, Wara W. Hyperfractionated irradiation for adults with brainstem gliomas. Int J Radiat Oncol Biol Phys 1991; 20: 757–60
   PubMed Web of Science ®Google Scholar
• Parsons J, Mendenhall W, Cassisi N, Isaacs J, Jr, Million R. Hyperfractionation for head and neck cancer. Int J Radiat Oncol Biol Phys 1988; 14: 649–58
   PubMed Web of Science ®Google Scholar
• Marcial V, Pajak T, Chang C, Tupchong L, Stetz J. Hyperfractionated photon radiation therapy in the treatment of advanced squamous cell carcinoma of the oral cavity, pharynx, larynx and sinuses, using radiation therapy as the only planned modality: (Preliminary report by the RTOG). Int J Radiat Oncol Biol Phys 1987; 13: 41–7
   PubMed Web of Science ®Google Scholar
• Fowler J F. Modelling altered fractionation schedules. Br J Radiol 1992, Suppl 24: 187–92
   Google Scholar
• Henriksson R, Franzén L, Littbrand B. Effects of sucralfate on acute and late bowel discomfort following radiotherapy of pelvic cancer. J Clin Oncol 1992; 10: 969–75
   PubMed Web of Science ®Google Scholar